• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INMODE LTD. MORPHEUS8; GEI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INMODE LTD. MORPHEUS8; GEI Back to Search Results
Model Number AG607401A
Device Problem Use of Incorrect Control/Treatment Settings (1126)
Patient Problem Erythema (1840)
Event Date 05/29/2022
Event Type  Injury  
Event Description
Residual pie in the shape of the tip footprints located in the lower abdomen one and a half year after treatment with morpheus8.
 
Manufacturer Narrative
Initially, the clinic provided photos of a patient with abdomen in a postpartum phase presenting multiple stretch marks and poor laxity, with residual erythematous tip footprints in the lower region.Based on the pictures of 5 months post treatment, it appears that the procedure was done in the beginning of the pregnancy, although pregnancy is listed as contraindication for morpheus8 treatment in ifu.The initial immune reaction could have been triggered by the application of a numbing cream with high percentage of anesthetics combined with aggressive treatment parameters (burst mode with too many passes).The healing was delayed both due to the peripheric treatment region and the fact that during pregnancy the skin undergoes mechanical stress and healing mechanisms are perturbed.Initially, inmode decided to monitor patient's healing progress as full resolution was expected despite the delayed timing.However, recently additional information was received from the provider upon inmode's attempt to inquire on patient's status, stating the patient hasn't resolved.Therefore, it was decided to report the incident due to longevity of the adverse event.Nevertheless, a gradual and continuous improvement of the skin texture as well as normalization and healing of the micro-lesions are expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MORPHEUS8
Type of Device
GEI
Manufacturer (Section D)
INMODE LTD.
tavor building (pob 533)
shaar yokneam
yokneam northern, north 20692 06
IS  2069206
Manufacturer (Section G)
INMODE LTD.
tavor building (pob 533)
shaar yokneam
yokneam northern, north 20692 06
IS   2069206
Manufacturer Contact
lina korsensky
tavor building (pob 533)
shaar yokneam
yokneam northern, north 20692-06
IS   2069206
MDR Report Key17859176
MDR Text Key324767143
Report Number3010511300-2023-00232
Device Sequence Number1
Product Code GEI
UDI-Device Identifier07290016633412
UDI-Public07290016633412
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K192695
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Administrator/Supervisor
Remedial Action Patient Monitoring
Type of Report Initial
Report Date 10/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberAG607401A
Device Catalogue NumberAG607401A
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/28/2023
Initial Date FDA Received10/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/04/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-